These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 19854351

  • 21. Tumor and stromal pathways mediating refractoriness/resistance to anti-angiogenic therapies.
    Crawford Y, Ferrara N.
    Trends Pharmacol Sci; 2009 Dec; 30(12):624-30. PubMed ID: 19836845
    [Abstract] [Full Text] [Related]

  • 22. Cellular interactions in the vascular niche: implications in the regulation of tumor dormancy.
    Favaro E, Amadori A, Indraccolo S.
    APMIS; 2008 Dec; 116(7-8):648-59. PubMed ID: 18834409
    [Abstract] [Full Text] [Related]

  • 23. Tumor angiogenesis--a potential target in cancer chemoprevention.
    Bhat TA, Singh RP.
    Food Chem Toxicol; 2008 Apr; 46(4):1334-45. PubMed ID: 17919802
    [Abstract] [Full Text] [Related]

  • 24. Angiogenesis in hematologic malignancies.
    Moehler TM, Neben K, Ho AD, Goldschmidt H.
    Ann Hematol; 2001 Dec; 80(12):695-705. PubMed ID: 11797109
    [Abstract] [Full Text] [Related]

  • 25. Anti-angiogenic therapy against gastrointestinal tract cancers.
    Iwasaki J, Nihira S.
    Jpn J Clin Oncol; 2009 Sep; 39(9):543-51. PubMed ID: 19531544
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Pathways mediating resistance to vascular endothelial growth factor-targeted therapy.
    Ellis LM, Hicklin DJ.
    Clin Cancer Res; 2008 Oct 15; 14(20):6371-5. PubMed ID: 18927275
    [Abstract] [Full Text] [Related]

  • 32. Tumor-vascular interactions and tumor dormancy.
    Naumov GN, Folkman J, Straume O, Akslen LA.
    APMIS; 2008 Oct 15; 116(7-8):569-85. PubMed ID: 18834403
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Targeting blood vessels for treatment of cancer...].
    Sonveaux P, Feron O.
    J Pharm Belg; 2003 Oct 15; 58(3):79-80. PubMed ID: 14619689
    [No Abstract] [Full Text] [Related]

  • 35. Molecular mechanisms regulating the angiogenic phenotype in tumors: clinical impact in the future.
    Aubry K, Barriere G, Chable-Rabinovitch H, Dutour A, Paraf F, Monteil J, Rigaud M.
    Anticancer Res; 2007 Oct 15; 27(5A):3111-9. PubMed ID: 17970051
    [Abstract] [Full Text] [Related]

  • 36. Circulating endothelial cells, bone marrow-derived endothelial progenitor cells and proangiogenic hematopoietic cells in cancer: From biology to therapy.
    Dome B, Timar J, Ladanyi A, Paku S, Renyi-Vamos F, Klepetko W, Lang G, Dome P, Bogos K, Tovari J.
    Crit Rev Oncol Hematol; 2009 Feb 15; 69(2):108-24. PubMed ID: 18768327
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Aquaporin-1: a novel promoter of tumor angiogenesis.
    Clapp C, Martínez de la Escalera G.
    Trends Endocrinol Metab; 2006 Feb 15; 17(1):1-2. PubMed ID: 16309919
    [Abstract] [Full Text] [Related]

  • 39. Bone marrow-derived cells: roles in solid tumor. Minireview.
    Wu XZ, Chen D, Xie GR.
    Neoplasma; 2007 Feb 15; 54(1):1-6. PubMed ID: 17203886
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.